45 results
treatment infections opportunistic prevention idsa diagnosis algorithm table chf heartfailure medications anticoagulation asthma ckd clinical copd criticalcare hfref mycobacterium nephrology
Summary of characteristics of Antianginal Drugs DRUG CLASS, ADVERSE EFFECTS AND DRUG INTERACTIONS #Antianginal #Medications #Cardiology
#Medications #Cardiology ... #Pharmacology # ... Management #Therapy
A practical guide to starting levothyroxine therapy Calculate full replacement dose: 1.6 mcg/kg/day Young, otherwise healthy patient: •
levothyroxine therapy ... replacement dose: 1.6 mcg ... Start at 25-50 mcg ... initiation #starting #management ... endocrinology #pharmacology
Choice of anticoagulant for treatment of pulmonary embolism • Malignancy - LMWH • To avoid parenteral
for treatment of pulmonary ... avoid parenteral therapy ... Once a day oral therapy ... clearance <30 mL ... anticoagulation #pharmacology
Vasopressors Table Rough properties by Target Receptor, Heart Rate/Inotropy, Systemic Vascular Resistance, Cardiac Output, Blood Pressure,
Blood Pressure, Pulmonary ... Dobutamine 2-20 mcg ... Epinephrine 0-20 mcg ... Properties #Table #Pharmacology ... #Effect #Management
IDSA Recommendations for Preventing and Treating Penicillium marneffei Infections in HIV-AIDS Preventing 1st Episode of Penicilliosis (Primary
areas Preferred Therapy ... 100 cells/mm3 g/mL ... Prevention #Treatment #management ... opportunistic #infections #HIVAIDS ... #pharmacology
Algorithm for Treatment of Chronic Thromboembolic Disease (CTEPH) Initial Imaging for Screening - V/Q scan - 90-100%
• Assess for Pulmonary ... Targeted Medical Therapy ... • Balloon Pulmonary ... karanpdesai #cteph #management ... #algorithm #cardiology
IDSA Recommendations for Treating Mucosal Candidiasis in HIV-AIDS Oropharyngeal Candidiasis: Initial Episodes (Duration of Therapy: 7–14 days) Preferred
days) Preferred Therapy ... suspension 4–6 mL ... Prevention #Treatment #management ... opportunistic #infections #HIVAIDS ... #pharmacology
IDSA Recommendations for Preventing and Treating Bacterial Enteric Infections in HIV-AIDS Preventing Bacterial Enteric Illness: • Antimicrobial
if MIC<0.12 ug/ml ... Preferred Therapy ... Prevention #Treatment #management ... opportunistic #infections #HIVAIDS ... #pharmacology
Stages in the development of HF and recommended therapy by stage. ACEI indicates angiotensin-converting enzyme inhibitor;
and recommended therapy ... resynchronization therapy ... ventricular hypertrophy; MCS ... ACCAHA #Algorithm #Management ... #Cardiology
IDSA Recommendations for Treating Visceral and Cutaneous Leishmaniasis in HIV-AIDS Treating Visceral Leishmaniasis - Preferred Therapy: •
Chronic Maintenance Therapy ... mm3 Preferred Therapy ... Prevention #Treatment #management ... opportunistic #infections #HIVAIDS ... #pharmacology
No results found for "MCL management pulmonary pharmacology hivaids cardiology therapy"
Try removing search terms or sorting by relevance
Or Upload an image for you and others searching for #MCL #management #pulmonary #pharmacology #hivaids #cardiology #therapy